Regulus: Q3 Earnings Snapshot

Carbonatix Pre-Player Loader

Audio By Carbonatix

SAN DIEGO (AP) — SAN DIEGO (AP) — Regulus Therapeutics Inc. (RGLS) on Thursday reported a loss of $14.1 million in its third quarter.

On a per-share basis, the San Diego-based company said it had a loss of 21 cents.

The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 18 cents per share.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RGLS at https://www.zacks.com/ap/RGLS

 

Salem News Channel Today

Sponsored Links

On Air & Up Next

  • That Kevin Show
    11:00PM - 1:00AM
     
    Broadcast from the heart of Times Square, Kevin McCullough takes America’s   >>
     
  • The Larry Elder Show
    1:00AM - 3:00AM
    The Larry Elder Show
    (888) 971-7243
     
    Larry Elder personifies the phrase “We’ve Got a Country to Save” The “Sage from   >>
     
  • The Chris Stigall Show
    3:00AM - 6:00AM
     
    Equal parts hilarity and desk-pounding monologues with healthy doses of skepticism and sarcasm.
     
  • That Kevin Show
    11:00PM - 1:00AM
     
    Broadcast from the heart of Times Square, Kevin McCullough takes America’s   >>
     

See the Full Program Guide